Svarstad E - Search Results

1

Renal Failure due to Excessive Intake of Almonds in the Absence of Oxalobacter formigenes.

Haaskjold YL, Drotningsvik A, Leh S, Marti HP, Svarstad E. Haaskjold YL, et al. Among authors: svarstad e. Am J Med. 2015 Dec;128(12):e29-30. doi: 10.1016/j.amjmed.2015.07.010. Epub 2015 Jul 30. Am J Med. 2015. PMID: 26235248 No abstract available.

2

A mother and daughter with unexplained renal failure.

Christiansen RE, Fiskerstrand T, Leh S, Haukanes BI, Singh AK, Fervenza FC, Svarstad E. Christiansen RE, et al. Among authors: svarstad e. Nephron Clin Pract. 2011;119(1):c1-9, discussion c7-8. doi: 10.1159/000327428. Epub 2011 May 27. Nephron Clin Pract. 2011. PMID: 21625178 Free article. No abstract available.

3

Mortality in patients with IgA nephropathy.

Knoop T, Vikse BE, Svarstad E, Leh S, Reisæter AV, Bjørneklett R. Knoop T, et al. Among authors: svarstad e. Am J Kidney Dis. 2013 Nov;62(5):883-90. doi: 10.1053/j.ajkd.2013.04.019. Epub 2013 Jun 21. Am J Kidney Dis. 2013. PMID: 23796906

4

Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.

Knoop T, Vågane AM, Vikse BE, Svarstad E, Magnúsdóttir BT, Leh S, Varberg Reisæter A, Bjørneklett R. Knoop T, et al. Among authors: svarstad e. Am J Nephrol. 2015;41(3):210-9. doi: 10.1159/000381403. Epub 2015 Apr 9. Am J Nephrol. 2015. PMID: 25872002 Free article.

5

Polyvinylpyrrolidone induced artefactual prolongation of activated partial thromboplastin times in intravenous drug users with renal failure.

Kristoffersen AH, Bjånes TK, Jordal S, Leh S, Leh F, Svarstad E. Kristoffersen AH, et al. Among authors: svarstad e. J Thromb Haemost. 2016 May;14(5):936-939. doi: 10.1111/jth.13299. Epub 2016 Apr 5. J Thromb Haemost. 2016. PMID: 26921123 Free article.

6

Low Birth Weight and Risk of Progression to End Stage Renal Disease in IgA Nephropathy--A Retrospective Registry-Based Cohort Study.

Ruggajo P, Svarstad E, Leh S, Marti HP, Reisæther AV, Vikse BE. Ruggajo P, et al. Among authors: svarstad e. PLoS One. 2016 Apr 19;11(4):e0153819. doi: 10.1371/journal.pone.0153819. eCollection 2016. PLoS One. 2016. PMID: 27092556 Free PMC article.

7

Reaccumulation of globotriaosylceramide in podocytes after agalsidase dose reduction in young Fabry patients.

Skrunes R, Svarstad E, Kampevold Larsen K, Leh S, Tøndel C. Skrunes R, et al. Among authors: svarstad e. Nephrol Dial Transplant. 2017 May 1;32(5):807-813. doi: 10.1093/ndt/gfw094. Nephrol Dial Transplant. 2017. PMID: 27190352

8

End Stage Renal Disease Predicts Increased Risk of Death in First Degree Relatives in the Norwegian Population.

Skrunes R, Svarstad E, Reisæter AV, Marti HP, Vikse BE. Skrunes R, et al. Among authors: svarstad e. PLoS One. 2016 Nov 9;11(11):e0165026. doi: 10.1371/journal.pone.0165026. eCollection 2016. PLoS One. 2016. PMID: 27828975 Free PMC article.

9

Pathomechanisms of renal Fabry disease.

Eikrem Ø, Skrunes R, Tøndel C, Leh S, Houge G, Svarstad E, Marti HP. Eikrem Ø, et al. Among authors: svarstad e. Cell Tissue Res. 2017 Jul;369(1):53-62. doi: 10.1007/s00441-017-2609-9. Epub 2017 Apr 12. Cell Tissue Res. 2017. PMID: 28401309 Review. No abstract available.

10

Long-Term Dose-Dependent Agalsidase Effects on Kidney Histology in Fabry Disease.

Skrunes R, Tøndel C, Leh S, Larsen KK, Houge G, Davidsen ES, Hollak C, van Kuilenburg ABP, Vaz FM, Svarstad E. Skrunes R, et al. Among authors: svarstad e. Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1470-1479. doi: 10.2215/CJN.01820217. Epub 2017 Jun 16. Clin J Am Soc Nephrol. 2017. PMID: 28625968 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page